Latest Partnerships News

New Murchison Gold Limited has officially commenced production at its Crown Prince Gold Mine ahead of schedule, marking its transition from explorer to gold producer. The company aims to ramp up to a 40,000 tonne monthly ore run rate by October 2025.

Red Sky Energy has secured regulatory approval to build the KN2 well site at its Killanoola Oil Project, setting the stage for drilling a promising new target that could boost production and revenues.

Noronex Limited has confirmed deeper, higher-grade copper mineralisation at its Fiesta Project in Namibia through diamond drilling, setting the stage for a substantial 7,000m Reverse Circulation drilling campaign funded by South32.

4DMedical has secured multi-year agreements to deploy its advanced lung imaging technology across Brazil and Australia, supporting national lung cancer screening programs and enhancing lung health diagnostics.

Hazer Group and First Graphene have signed a non-binding MOU to explore innovative applications for Hazer’s proprietary graphite, aiming to capitalize on rising global demand amid supply constraints.

Pathkey.AI’s TrialKey platform has demonstrated a 73% alignment with actual biotech trial outcomes, showing an average hypothetical share price gain of 76%, underscoring AI’s growing role in clinical trial prediction and biotech investing.

Prophecy International flags higher churn and softer US sales for its Snare product, prompting a conservative FY2026 outlook and $3.2 million in annual cost savings.

Memphasys has inked a five-year exclusive distribution agreement with Middle East leader ITL, unlocking a $325,000 initial order for its Felix™ fertility system upon CE Mark approval. This deal opens access to 15 countries and over 350 IVF clinics, setting the stage for rapid regional adoption.

QuickFee Limited has divested its US Pay Now payments business for US$26.35 million while keeping its US Finance operations and loan book, withdrawing FY26 earnings guidance amid ongoing tax and transaction cost assessments.

Cambium Bio has secured a strategic partnership with French pharmaceutical leader Benta SAS to commercialise its regenerative dry eye treatment, Elate Ocular, across Europe and the Middle East. This follows a second platelet-lysate licensing deal within days, underscoring growing industry confidence in Cambium’s platform.

Gowing Bros Limited has locked in a $10.4 million financing facility from Commonwealth Bank to fund civil works and council contributions at its Sawtell Commons development.

4DS Memory Limited has had its trading suspension lifted following an important announcement about its collaboration with development partners to chart the future of its technology beyond 2025.